Glenmark Pharmaceuticals Limited

Pharmaceutical industry in India Q3 FY26 Results: India Formulations Shine as US Pricing Remains a Drag

Q3 FY26 Performance SnapshotThe Indian pharma sector delivered a steady Q3 FY26, with performance largely driven by domestic strength.Sales Growth: +13% YoYOperating Profit: +12% YoYPAT Growth: +1% YoYWhile revenue and operating profit expanded in tandem, net profit growth remained muted due to m...

Glenmark Pharma Share Price Rises as Subsidiary Bags $700 Million Licensing Deal with AbbVie

Stock Market Today Update: Glenmark Pharma witnessed a notable uptick in its share price on September 9, following a major licensing deal announcement by its wholly owned subsidiary, Ichnos Glenmark Innovation (IGI).Market PerformanceOn September 9, Glenmark Pharma shares climbed over 2% in early...

Glenmark Pharma’s Share Price Remains Flat Amid USFDA Warning Letter to Indore Facility

Market PerformanceGlenmark Pharma's share price remained flat at ₹2,183 apiece during early trading hours at 9:35 AM on Monday, July 14.The stock is currently under F&O ban, restricting the creation of any new derivative positions.Glenmark Pharma's share price has surged 35.2% so far in 2025,...

Sensex and Nifty News: Markets Slide as TCS Earnings Disappoint and Global Tariff Tensions Mount

Market Performance: Sensex and Nifty Plunge Amid Broad-Based SelloffThe Indian stock market faced a steep decline on Friday, July 11, driven by disappointing corporate earnings and rising global uncertainties.Sensex dropped by 690 points or 0.83%, closing at 82,500.47.Nifty 50 ended at 25,149.85,...

Glenmark Pharma Share Price Soars 15% After Record-Breaking Licensing Deal with AbbVie

Market PerformanceGlenmark Pharma share price witnessed a sharp rally of 15% on July 11, reaching a 52-week high of ₹2,189.60. The stock initially breached the 10% upper circuit in early trading and continued to surge, eventually reaching the 15% limit.Over various time frames, Glenmark Pharma ha...

Pharma Stocks Slide: Aurobindo Pharma, Lupin, Dr Reddy’s, and Others See Sharp Decline Amid Tariff Concerns

Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...

Pharma Stocks Buck Market Trend as Nifty Pharma Emerges Sole Gainer; Ajanta Pharma, Ipca Labs Lead Surge

Market PerformanceDespite a weak broader market on June 12, Nifty Pharma outshone as the only sectoral gainer, climbing nearly 1% to 22,243 in morning trade.This uptrend in pharma shares was primarily driven by easing global trade concerns after U.S. President Donald Trump's announcement regardin...